Additional Metadata
Persistent URL dx.doi.org/10.1182/blood-2018-03-839688, hdl.handle.net/1765/115022
Journal Blood
Citation
Langerak, A.W, Ritgen, M, Goede, V, Robrecht, S., Bahlo, J., Fischer, K, … van Dongen, JJM. (2019). Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab. Blood, 133(5), 494–497. doi:10.1182/blood-2018-03-839688